Viewing Study NCT02918318


Ignite Creation Date: 2025-12-25 @ 4:56 AM
Ignite Modification Date: 2026-03-03 @ 11:15 AM
Study NCT ID: NCT02918318
Status: COMPLETED
Last Update Posted: 2025-04-29
First Post: 2016-09-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-12-12
Start Date Type: ACTUAL
Primary Completion Date: 2019-08-19
Primary Completion Date Type: ACTUAL
Completion Date: 2019-12-13
Completion Date Type: ACTUAL
First Submit Date: 2016-09-27
First Submit QC Date: None
Study First Post Date: 2016-09-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-08-18
Results First Submit QC Date: None
Results First Post Date: 2020-10-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-25
Last Update Post Date: 2025-04-29
Last Update Post Date Type: ACTUAL